RxDoctor Payments DataLook up a doctor →

Lydie Hazan

Beverly Hills, CANPI 1215013446

Payments from drug & device makers

$1,937,118in general payments, 2019–2025

Across 214 payments — averaging $9051.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vanda Pharmaceuticals Inc.$571K
  • Amgen$293K
  • Cepheid$284K
  • Eli Lilly$245K
  • Rhythm Pharmaceuticals, Inc.$178K
  • Mitsubishi Tanabe Pharma Development America, Inc.$72K
  • plus $294K from 15 others
$346,826in research payments, 2019–2025

Across 3 payments — averaging $115,609 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$318K
  • Celltrion, Inc.$29K

What the payments were for

  • Consulting fees$1,02326%
  • Travel & lodging$1,95450%
  • Food & beverage$89423%

General payments by program year

19
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →